- Home
- TRDA vs UAN Comparison
TRDA vs UAN Comparison
Compare TRDA & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- UAN
- Stock Information
- Founded
- TRDA 2016
- UAN 2007
- Country
- TRDA United States
- UAN United States
- Employees
- TRDA N/A
- UAN N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- UAN Agricultural Chemicals
- Sector
- TRDA Health Care
- UAN Industrials
- Exchange
- TRDA Nasdaq
- UAN Nasdaq
- Market Cap
- TRDA 609.7M
- UAN 710.0M
- IPO Year
- TRDA 2021
- UAN 2011
- Fundamental
- Price
- TRDA $17.63
- UAN $73.99
- Analyst Decision
- TRDA Strong Buy
- UAN
- Analyst Count
- TRDA 3
- UAN 0
- Target Price
- TRDA $21.67
- UAN N/A
- AVG Volume (30 Days)
- TRDA 166.9K
- UAN 23.7K
- Earning Date
- TRDA 11-05-2024
- UAN 10-28-2024
- Dividend Yield
- TRDA N/A
- UAN 10.28%
- EPS Growth
- TRDA N/A
- UAN N/A
- EPS
- TRDA 3.04
- UAN 4.68
- Revenue
- TRDA $239,397,000.00
- UAN $532,775,999.00
- Revenue This Year
- TRDA $39.06
- UAN N/A
- Revenue Next Year
- TRDA N/A
- UAN N/A
- P/E Ratio
- TRDA $5.76
- UAN $15.45
- Revenue Growth
- TRDA 451.22
- UAN N/A
- 52 Week Low
- TRDA $10.75
- UAN $60.50
- 52 Week High
- TRDA $18.17
- UAN $88.94
- Technical
- Relative Strength Index (RSI)
- TRDA 61.79
- UAN 67.63
- Support Level
- TRDA $15.65
- UAN $67.99
- Resistance Level
- TRDA $18.01
- UAN $71.71
- Average True Range (ATR)
- TRDA 0.75
- UAN 2.06
- MACD
- TRDA 0.17
- UAN 0.62
- Stochastic Oscillator
- TRDA 86.52
- UAN 91.84
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.